Independent fund research. Built on SEC filings.

How we research funds

ETF · Large Value · Vanguard

Vanguard U.S. Value Factor ETF (VFVA)

Ticker VFVA · Index fund · Since 2018-02-13 · · Holdings as of May 31, 2026

Expense ratio
0.13%$13/yr per $10k
Net assets
$825.9Mall share classes
Holdings
653

Bottom line

Is VFVA a good fund? The bottom line

VFVA is an index large value ETF from Vanguard.

Annual fees run 0.13% — about $13 a year on every $10,000 invested, cheaper than 95% of large value funds we track.

With $826 million in net assets and 653 holdings, its largest position is CVS Health Corp (0.9%) and the top 10 make up 8.3% of the portfolio.

What stands out

  • Low cost: cheaper than 95% of large value peers
  • Broadly diversified (653 holdings)

Updated Nov 19, 2026

What VFVA invests in

Vanguard U.S. Value Factor ETF (the Fund) seeks to provide long-term capital appreciation by investing in stocks with relatively lower share prices relative to fundamental values as determined by the advisor.

The Fund employs an active management approach, investing primarily in U.S. common stocks with the potential to generate higher returns relative to the broad U.S. equity market by selecting stocks with relatively lower share prices relative to fundamental values as determined by the advisor. The Funds portfolio includes a diverse mix of companies representing many different market sectors and industry groups. The advisor uses a quantitative model to evaluate all of the securities in an investment universe comprised of U.S. large-, mid-, and small-capitalization stocks and to construct a U.S. equity portfolio that seeks to achieve exposure to securities with lower prices relative to fundamental measures of value subject to a rules-based screen designed to promote diversification and to mitigate exposure to certain less liquid stocks. Securities with lower prices relative to fundamental…

From the fund's prospectus (filed Mar 27, 2026).

VFVA performance

Fund calendar-year total returns, 2019–2025 2019: +24.9%; 2020: +2.3%; 2021: +37.0%; 2022: −3.8%; 2023: +17.2%; 2024: +7.8%; 2025: +14.7% +24.9% 2019 +2.3% 2020 +37.0% 2021 −3.8% 2022 +17.2% 2023 +7.8% 2024 +14.7% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
VFVA———
Large Value median+13.6%+11.3%+10.2%

Source: Fund prospectus, as of

Full VFVA performance history →

What VFVA costs

On a $10,000 investment, VFVA's 0.13% expense ratio costs about $13 a year. The prospectus estimates $166 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.

See the full VFVA fee table →

VFVA top 10 holdings

#Holding% of fund
1CVS Health Corp0.95%
2EOG Resources Inc0.89%
3General Motors Co0.86%
4Bristol-Myers Squibb Co0.85%
5Verizon Communications Inc0.85%
6Cigna Group/The0.85%
7AT&T Inc0.78%
8FedEx Corp0.77%
9Elevance Health Inc0.76%
10Accenture PLC0.72%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 8.3% of the fund. See all top 25 holdings and asset mix →

Alternatives to VFVA

More funds like VFVA →

VFVA FAQ

What is the expense ratio of VFVA?
VFVA's expense ratio is 0.13%, which works out to about $13 a year for every $10,000 invested. The prospectus estimates total costs of $166 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is VFVA a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 95% of large value peers; broadly diversified (653 holdings). This is general information, not personalized advice.
What does VFVA hold?
VFVA's largest holdings are CVS Health Corp (0.9%), EOG Resources Inc (0.9%), General Motors Co (0.9%), Bristol-Myers Squibb Co (0.9%), Verizon Communications Inc (0.8%). It holds 653 positions in total as of May 31, 2026 (SEC Form N-PORT).
Who manages VFVA?
VFVA is offered by Vanguard through Vanguard Wellington Fund.